Correlation Between ANI Pharmaceuticals and Neurocrine Biosciences
Can any of the company-specific risk be diversified away by investing in both ANI Pharmaceuticals and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ANI Pharmaceuticals and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ANI Pharmaceuticals and Neurocrine Biosciences, you can compare the effects of market volatilities on ANI Pharmaceuticals and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ANI Pharmaceuticals with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of ANI Pharmaceuticals and Neurocrine Biosciences.
Diversification Opportunities for ANI Pharmaceuticals and Neurocrine Biosciences
0.54 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between ANI and Neurocrine is 0.54. Overlapping area represents the amount of risk that can be diversified away by holding ANI Pharmaceuticals and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and ANI Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ANI Pharmaceuticals are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of ANI Pharmaceuticals i.e., ANI Pharmaceuticals and Neurocrine Biosciences go up and down completely randomly.
Pair Corralation between ANI Pharmaceuticals and Neurocrine Biosciences
Given the investment horizon of 90 days ANI Pharmaceuticals is expected to under-perform the Neurocrine Biosciences. In addition to that, ANI Pharmaceuticals is 1.02 times more volatile than Neurocrine Biosciences. It trades about -0.03 of its total potential returns per unit of risk. Neurocrine Biosciences is currently generating about -0.02 per unit of volatility. If you would invest 14,048 in Neurocrine Biosciences on August 24, 2024 and sell it today you would lose (1,548) from holding Neurocrine Biosciences or give up 11.02% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ANI Pharmaceuticals vs. Neurocrine Biosciences
Performance |
| Timeline |
| ANI Pharmaceuticals |
| Neurocrine Biosciences |
ANI Pharmaceuticals and Neurocrine Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ANI Pharmaceuticals and Neurocrine Biosciences
The main advantage of trading using opposite ANI Pharmaceuticals and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ANI Pharmaceuticals position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.| ANI Pharmaceuticals vs. Phibro Animal Health | ANI Pharmaceuticals vs. Prestige Brand Holdings | ANI Pharmaceuticals vs. Alkermes Plc | ANI Pharmaceuticals vs. Dr Reddys Laboratories |
| Neurocrine Biosciences vs. Catalent | Neurocrine Biosciences vs. Amphastar P | Neurocrine Biosciences vs. ANI Pharmaceuticals | Neurocrine Biosciences vs. Alkermes Plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Transaction History View history of all your transactions and understand their impact on performance |